IL157444A0 - Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same - Google Patents

Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same

Info

Publication number
IL157444A0
IL157444A0 IL15744402A IL15744402A IL157444A0 IL 157444 A0 IL157444 A0 IL 157444A0 IL 15744402 A IL15744402 A IL 15744402A IL 15744402 A IL15744402 A IL 15744402A IL 157444 A0 IL157444 A0 IL 157444A0
Authority
IL
Israel
Prior art keywords
macrophase
diagnostic
labeled
pharmaceutical compositions
same
Prior art date
Application number
IL15744402A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of IL157444A0 publication Critical patent/IL157444A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15744402A 2001-02-23 2002-02-22 Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same IL157444A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27095401P 2001-02-23 2001-02-23
PCT/US2002/005156 WO2002067761A2 (en) 2001-02-23 2002-02-22 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque

Publications (1)

Publication Number Publication Date
IL157444A0 true IL157444A0 (en) 2004-03-28

Family

ID=23033552

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15744402A IL157444A0 (en) 2001-02-23 2002-02-22 Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same

Country Status (12)

Country Link
US (2) US6869590B2 (cs)
EP (1) EP1377321A4 (cs)
JP (1) JP2004530654A (cs)
CN (1) CN1622832A (cs)
AU (1) AU2002254000A1 (cs)
BR (1) BR0207521A (cs)
CA (1) CA2438174A1 (cs)
CZ (1) CZ20032564A3 (cs)
HU (1) HUP0400027A3 (cs)
IL (1) IL157444A0 (cs)
MX (1) MXPA03007534A (cs)
WO (1) WO2002067761A2 (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4868698B2 (ja) 2001-05-02 2012-02-01 パーデュー・リサーチ・ファウンデーション マクロファージが仲介する疾患の治療および診断
EP1401479B1 (en) * 2001-06-04 2007-04-18 The General Hospital Corporation Detection and therapy of vulnerable plaque with photodynamic compounds
US20060148683A1 (en) * 2001-10-16 2006-07-06 Mcmurry Thomas J Detection and treatment of intravascular lesions
US8043603B2 (en) * 2002-02-07 2011-10-25 Endocyte, Inc. Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
US8043602B2 (en) 2002-02-07 2011-10-25 Endocyte, Inc. Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
US7018614B2 (en) * 2002-11-05 2006-03-28 Eastern Isotopes, Inc. Stabilization of radiopharmaceuticals labeled with 18-F
CN100478035C (zh) * 2002-11-05 2009-04-15 离子束应用股份有限公司 用18-f标记的放射性药物的稳定化
GB0228490D0 (en) * 2002-12-06 2003-01-08 Amersham Plc Novel imaging compounds
US7297154B2 (en) 2003-02-24 2007-11-20 Maxwell Sensors Inc. Optical apparatus for detecting and treating vulnerable plaque
US7153299B1 (en) 2003-02-24 2006-12-26 Maxwell Sensors Inc. Optical apparatus for detecting and treating vulnerable plaque
US7803352B2 (en) * 2003-03-07 2010-09-28 John Steele Fisher Method for continuous visualization of a blood clot or plaque in body lumen
ATE412897T1 (de) * 2003-05-30 2008-11-15 Purdue Research Foundation Diagnoseverfahren für atherosklerose
US7829597B2 (en) 2003-10-03 2010-11-09 Merck, Sharp & Dohme, Inc. Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
EP1602931A1 (en) * 2004-06-03 2005-12-07 Universiteit Leiden SR-A antagonists
WO2006012201A1 (en) * 2004-06-25 2006-02-02 The Regents Of The University Of California Nanoparticles for imaging atherosclerotic plaque
US7575738B2 (en) 2004-08-13 2009-08-18 General Electric Company Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
CN101128152A (zh) * 2004-12-23 2008-02-20 普渡研究基金会 发射正电子段层成像方法
WO2007006041A2 (en) 2005-07-05 2007-01-11 Purdue Research Foundation Imaging and therapeutic method using monocytes
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
WO2007038346A2 (en) 2005-09-23 2007-04-05 Purdue Research Foundation Multiphoton in vivo flow cytometry method and device
US20070196282A1 (en) * 2006-02-21 2007-08-23 Siemens Medical Solutions Usa, Inc. Medical diagnostic ultrasound with temperature-dependent contrast agents
EP2087337A4 (en) 2006-11-03 2010-09-08 Purdue Research Foundation METHOD AND DEVICE FOR EX-VIVO FLOW CYTOMETRY
EP2109466B1 (en) * 2007-02-07 2014-11-12 Purdue Research Foundation Positron emission tomography imaging method
WO2008148001A2 (en) * 2007-05-25 2008-12-04 Purdue Research Foundation Method of imaging localized infections
MX2010005122A (es) * 2007-11-07 2010-08-18 Ge Healthcare Bv Estabilizacion de radiofarmaceuticos.
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
CN101970015B (zh) 2008-01-08 2014-05-07 兰休斯医疗成像公司 作为显像剂的n-烷氧基酰胺共轭物
US20100178245A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
US8877157B2 (en) 2009-07-08 2014-11-04 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
US20150023873A1 (en) 2011-11-11 2015-01-22 Lantheus Medical Imaging, Inc. Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging
US10537842B2 (en) 2015-06-09 2020-01-21 Cummins Filtration Ip, Inc. Systems and methods for utilizing a low-friction rotating coalescer contact seal
CN111212606B (zh) * 2017-08-15 2024-03-01 皇家飞利浦有限公司 频率可调谐血管内超声设备
WO2019118592A1 (en) * 2017-12-12 2019-06-20 Massachusetts Institute Of Technology Cell-permeable imaging sensors and uses thereof
KR102207372B1 (ko) * 2020-03-31 2021-01-27 재단법인 아산사회복지재단 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물
CN116473020B (zh) * 2022-11-18 2025-04-25 新乡医学院 一种Macrosialin基因缺失动脉粥样硬化小鼠模型的构建方法及其应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4577042A (en) * 1983-03-17 1986-03-18 California Institute Of Technology Homogeneous coordination compounds as oxidation catalysts
US4678667A (en) 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
US4752141A (en) 1985-10-25 1988-06-21 Luxtron Corporation Fiberoptic sensing of temperature and/or other physical parameters
JPH07110815B2 (ja) 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム 画像及びスペクトル向上(およびスペクトルシフト)のためのポリキレ−ト剤
US4885363A (en) 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
MX174467B (es) 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
GB8603537D0 (en) 1986-02-13 1986-03-19 Parker D Conjugate compound
GB8719042D0 (en) 1987-08-12 1987-09-16 Parker D Conjugate compounds
WO1989011475A1 (en) 1988-05-25 1989-11-30 The United States Of America, As Represented By Th Macrocyclic chelates and methods of use thereof
US4923985A (en) 1988-05-25 1990-05-08 The United States Of America As Represented By The Department Of Health & Human Services Process for synthesizing macrocyclic chelates
US5756065A (en) 1988-06-24 1998-05-26 The Dow Chemical Company Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
LU87403A1 (fr) 1988-12-06 1990-07-10 Oreal Procede de teinture de fibres keratiniques avec un hydroxyindole,associe a un derive quinonique
DE69024826T2 (de) 1989-02-10 1996-06-27 Celltech Therapeutics Ltd Aza-Macrozyklen und Verfahren zu deren Herstellung
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US5364613A (en) 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US4986671A (en) 1989-04-12 1991-01-22 Luxtron Corporation Three-parameter optical fiber sensor and system
US5087440A (en) 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
AU7587091A (en) 1990-03-26 1991-10-21 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A fonctionalized complexand
US5275594A (en) 1990-11-09 1994-01-04 C. R. Bard, Inc. Angioplasty system having means for identification of atherosclerotic plaque
AU663572B2 (en) 1992-03-27 1995-10-12 Nihon Medi-Physics Co., Ltd. Tetraazacyclododecane derivative and its use
US5310535A (en) 1992-04-24 1994-05-10 The Dow Chemical Company Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
US5744120A (en) 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5428156A (en) 1993-04-02 1995-06-27 Associated Universities, Inc. Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging
WO1995026206A1 (en) 1994-03-28 1995-10-05 The Regents Of The University Of California Method for preparing radionuclide-labeled chelating agent-ligand complexes
IT1283218B1 (it) 1996-03-08 1998-04-16 Bracco Spa Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi
US5879659A (en) 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
US5848367A (en) 1996-09-13 1998-12-08 Sony Corporation System and method for sharing a non-volatile memory element as a boot device
US6403054B1 (en) 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
WO1999007382A1 (en) 1997-08-06 1999-02-18 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
AU755564B2 (en) 1998-06-20 2002-12-12 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
EP1100484A1 (en) * 1998-07-20 2001-05-23 SmithKline Beecham Corporation Macrophage scavenger receptor antagonists
EP1100486A4 (en) 1998-07-30 2003-01-15 Smithkline Beecham Corp ANTAGONISTS OF THE MACROPHAGE CATCHER RECEPTORS

Also Published As

Publication number Publication date
EP1377321A4 (en) 2006-01-11
JP2004530654A (ja) 2004-10-07
CZ20032564A3 (cs) 2004-09-15
HUP0400027A2 (hu) 2004-04-28
CA2438174A1 (en) 2002-09-06
BR0207521A (pt) 2004-06-01
US20020127181A1 (en) 2002-09-12
US20040057900A1 (en) 2004-03-25
MXPA03007534A (es) 2003-12-04
WO2002067761A2 (en) 2002-09-06
EP1377321A2 (en) 2004-01-07
HUP0400027A3 (en) 2006-01-30
WO2002067761A3 (en) 2003-02-13
US6869590B2 (en) 2005-03-22
CN1622832A (zh) 2005-06-01
US6974567B2 (en) 2005-12-13
AU2002254000A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
IL157444A0 (en) Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same
HUP0302969A3 (en) Npyy5 antagonists, pharmaceutical compositions containing them and their use
HUP0303081A3 (en) Thrombin receptor antagonists, pharmaceutical compositions containing them and their use
HUP0400251A3 (en) 5-ht receptor ligands and uses thereof and pharmaceutical compositions containing them
HUP0500880A2 (en) Cxcr3 antagonists and pharmaceutical compositions thereof
HUP0500107A3 (en) 1-alkyl-1-azoniabicyclo[2.2.2.]octane carbamate derivatives, pharmaceutical compositions comprising thereof and their use as muscarinic receptor antagonists
IL158041A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
SI1381346T1 (sl) Farmacevtski sestavki, ki vsebujejo formoterol
HUP0303258A3 (en) N-substituted nonaryl-heterocyclic nmda/nr2b antagonists and pharmaceutical compositions containing them
HUP0303651A3 (en) N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor and pharmaceutical compositions containing them
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL163366A (en) Glucocorticoid mimetics, pharmaceutical compositions thereof and uses thereof for the preparation of pharmaceutical compositions
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
GB0111597D0 (en) Pharmaceutical compositions
IL169575A0 (en) Calcium-sensing receptor antagonist compounds and pharmaceutical compositions containing the same
IL165388A0 (en) Macrolide compounds and pharmaceutical compositions containing the same
HUP0302382A3 (en) Il-8 receptor antagonists and pharmaceutical compositions containing them
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
HUP0400850A3 (en) Oral pharmaceutical compositions
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
GB0108470D0 (en) Pharmaceutical compositions and their use
HUP0300599A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
HUP0302003A3 (en) Il-8 receptor antagonists and pharmaceutical compositions containing them